CLINICS IN PERINATOLOGY ELSEVIER SAUNDERS Clin Perinatol 32 (2005) 1059-1093 Cumulative Index 2005 Vote: Page numbers of article titles are in boldface type. Age, maternal, multiple gestations and, Abdomen 311—312. 320 abscess, in radiography in, 797—798 Agency for Health Care Policy and Research, injury within, 32—33 National Summit on Patient Safety and Abortion, spontaneous, in infections, 526—527 Medical Errors, on kernicterus, 130— 13] \bruptio placenta, in multiple gestations, 405 Airway, obstruction of, ex utero intrapartum Abscess, radiography in treatment for, 936 abdominal, 797-798 Alarm systems, effectiveness of, for safety brain, 793 102-103 epidural, 792—793 \lpha-fetoprotein, in triple screen, for Down psoas, 799 —800 syndrome, in twin pregnancies, 375— 382 Accelerated ventricular rhythm, 900 Altered flow theory, of heart disease, 880— 884 Accessory pathway, defects of, in supraventricular tachycardia, 939 Alternate dispute resolution, 243 Acidemia, 88 Amantadine, for influenza, 730 Acidosis American Academy of Pediatrics, on in asphyxia, measurement of, 62—63 kernicterus prevention, 112392 -13IQ4A metabolic, in heart disease, 931 American Association of Nurse Attorneys, 27 Acute respiratory distress syndrome, In pyelonephritis, 759 American College of Obstetricians and Gynecologists, asphyxia criteria of, Acycloy ll 7 0 7) for herpes simplex virus infections, Amiodarone, for arrhythmias 634-635. 663-665 for varicella, 685 —687 fetal, 893. 900, 902 neonatal, 983-984 Adenosine, for arrhythmias, 895, 940, 980-98? Amniocentesis in bacterial culture, 585, 589 Administration, of drugs, error prevention in, in cytomegalovirus infections, 677 116-117 in multiple gestations, 355~— 358, 446 versus chorionic villus sampling, Administrative compensation model, for med- ical injuries, 218 2] 359~— 360 Adrenal gland, injury of, 32—33 Amnionitis. See Intra-amniotic infections Advance care planning, 161 Amnioreduction, in twin-— twin transfusion 481-—483. 502-503. 87] Advance lists of avoidable events, 221 95 Amniotic membrane, thickness of, in Adverse events, in medication errors as. Se¢ chorionicity determination, 478 Medication errors. Amoxicillin Affymetrix genotyping chip, in heart for Chlamydia trachomatis infections, 639 disease, 828 for neonatal sepsis prevention, 609 0095-5108/05/$ see front matter © 2005 Elsevier r Inc. All rights reserved doi: 10.1016/S0095-5 108(05)00110-7 perinatology.theclinics.com 1060 CUMULATIVE INDEX Amoxicillin-clavulanate, for neonatal sepsis Aorta, coarctation of prevention, 609-610 pregnancy contraindicated in, 914 surgical management of, 957—958 Ampicillin for intra-amniotic infections, 593-594 Aortic arch for neonatal sepsis prevention, 607 anomalies of for pyelonephritis, 756 embryology of, 838—839 Ampicillin-sulbactam in DiGeorge syndrome, 965, for endometritis, 810, 812 971, 973 surgical management of, 957 for intra-amniotic infections, 593 development of, 838—839 Amrinone (inamrinone), for heart disease, Aortic root, dilated, 882 989 —99() Amsel’s criteria, for bacterial vaginosis, Aortic valve development of, 836—838 643 —644 stenosis of Anaerobic infections, intra-amniotic, 593 in fetus, 863-864, 880-881 pregnancy contraindicated in, 914 Analgesia, epidural. See Epidural analgesia valvuloplasty of, 863-864 Anemia Apnea fetal home monitoring for, standard of care in human parvovirus B19 for, 259-261 infections, 701 —703 in prostaglandin therapy, 934 in twin—twin transfusion syndrome, 868 Apolipoprotein E, in heart disease, 1047 maternal, in multiple gestations iron-deficiency, 416—417, Appellate review, in negligence litigation, 188 432-433 Appendicitis, radiography in, 795—796 physiologic, 432 Applicable law, in trial, 181—183 Angiography, in infections, radiation exposure in, 790—791 Aprostadil, for congenital heart disease, 931 —934 Angiotensin-converting enzyme inhibitors, for Arrhythmias. See also specific arrhythmias hypertension, 985—986 fetal, 891-912 drug therapy for, 892-894 Anhydramnios, in twin—twin transfusion ectopic, 907—908 syndrome, 348 —349 future research on, 907, 909 Anonymous reporting, of errors, 98 heart block, 902—906 modalities for, 891—892 Anthrax, 770—771 sudden death in, 907 tachyarrhythmias, 894-902 Antiarrhythmics, for neonatal heart disease, treatment of, 984 979-984 maternal, treatment of, 917 Antibiotics neonatal for endometritis, 810—812 drugs for, 979-984 for intra-amniotic infections, 593 —594 from umbilical venous catheter for meningitis, standard of care for, misplacement, 147 254-256 Arterial switch operation, for transposition of for neonatal sepsis prevention, 604—611 great arteries, 955, 1050 for preterm birth prevention, 580—588 for urinary tract infections, 751-753, Arteriovenous anastomoses 756—758 in selective fetal growth lag, 488 resistance to, in group B streptococci, 611 in twin--twin transfusion, 479 Antibody(ies), to Toxoplasma gondii, testing Ask-tell-ask format, in communication, 162 for, 711—717 Asphyxia, 61-76 Anticipatory empathy, in communication, 165 brain injury timing and, 69 causes of, 12 Antihypertensives, for neonatal heart disease, factors affecting, 12—13 985—986 hypocarbia in, 88—89 CUMUL ATIVE INDEX hypoglycemia in, 87 SS \trial flutter, 894-895, 899-900 hypotension in, 89—90 Atrial septal defect in intra-amniotic infections, 595 embryology of, 834 835 kidney function in, 68—69 growth failure in, 1021 labor admission test for, 11—12 in DiGeorge syndrome, 965 liver function tests in, 68 septostomy in, 949 nucleated red blood cells in, 64 organ dysfunction in, 67—68 Atrial septostomy platelet count in, 67 for atrial septal defect, 949 prevention of, 1-17 for restrictive arterial communication, critical conduct intervals in, 6—9 866—867 foreseeability of harm concept in, for transposition of great arteries, 954 79 Atrial tachycardia, 984 methods for, 10 16 notice in, 3—6 Atrioventricular block. See Heart block quality care management in, 9— 10 Atrioventricular valve(s) umbilical artery pH in, 63—64 common, embryology of, 835 Aspiration, meconium, resuscitation in, 83—8 dev elopment of, 835 regurgitation of Assessment, nursing, failure to pet form. as fetal circulation in negligence, 280-281 growth failure in, Assisted reproductive technology, multiple Atrium gestations from, 315-328 central venous catheter age factors 1n, 320 septation of, 834—835 birth defects in, 3 32 5 umbilical venous catheter misplacen 17 complications of, 318 in, 147 definition of, 316 Atropine Down syndrome screening and, 378 embryo quality selection in, 3 979 for arrhythmias, 98] for complete heart block embryo transfer in, 318—324 epidemiology of, 309-311 \ttorneys’ fees, limitation of guidelines for, 320 Augmentation, of labor, in twin | history of, 315 457-458 implantation rates in, 320—321 intracytoplasmic sperm injection in, Automatic atrial tachycardia male factors in, 325 fetal, 899 maternal risk factors in, 405 406 neonatal, 980 monozygotic rate in, 324 outcomes of, 506 509 Automation, for medication error preventi ovulation induction in, - 73 is 4—325 114—117 preimpl2a77n tati4o2n genetic diagnosis in, Avidity test, in toxoplasmosis prevention of, with single embryo Avoidable classes of events, 2 transfer, 323-324 Avulsion, of brachial plexus, statistics on, 316—317 Association studies, in heart disease, 827—828 Axonotmesis, in brachial plexus injuries 2 5 \zithromycin Asynchronous delivery, in multiple gestations, 09 27 for chancroid, 636 436-43 for Chlamydia trachomatis infections, 639 Atenolol, for arrhythmias, 980 for gonorrhea, 637 Atrial bigeminy, fetal, 907—908 tor lymphogranuloma venereum, for syphilis, 630 Atrial communication, restrictive hypoplastic left heart syndrome and, 865-866 transposition of great arteries and, Bacteremia 866— 867 gonococcal, 638 Atrial ectopic tachycardia, 898-899 in pyelonephritis, 758 1062 CUMULATIVE INDEX Bacterial vaginosis, 617—627 extracranial, 20—22 diagnosis of, 618—620, 643-644 facial, 29-30 epidemiology of, 618 facial nerve, 26—27 historical review of, 617—618 fractures, 31 —32 microbiology of, 618, 643 intra-abdominal, 32 preterm birth in, 541, 574 intracranial, 22—24 screening for, 620-62] laryngeal nerve, 28 treatment of, 581 —582, 621-624, malpractice and. See Malpractice. 644-645 muscular torticollis, 30—31 nasal septal, 29 Bacteriuria, asymptomatic, 582, 749-753 nerve, 25—29 Bacteroides infections ocular, 30 bacterial vaginosis, 618 phrenic nerve, 27—28 stillbirth in, 528 prevention of, 217, 225-226 risk factors for, 19 Bad faith litigation, 188—189 spinal cord, 28—29 Bad news, communication of, 160—161 subarachnoid hemorrhage, 24 subdural hemorrhage, 23 —24 Balloon catheters, for labor induction, in twin subgaleal hemorrhage, 20—21 pregnancies, 457—458 Birthweight, in multiple births, 496-497 Barcodes, in medication error prevention, average, 403 116-117 maternal body composition and, Bed rest, for multiple gestations, 396, 414-415 433-434, 447 maternal weight gain and, 410—413 Behavioral disorders, in DiGeorge syndrome, Bladder, infection of, 750, 753-754 969-970 Blastocyst, cardiomyocyte origin in, 828 Benzathine penicillin G, for syphilis, 630-631 Blastomycosis, 734 Betamethasone for fetal atrioventricular block, 903 Blood culture for fetal lung maturation, 585 in endometritis, 808 in pyelonephritis, 755-756 Bicarbonate for arrhythmias, 981] Blood volume, in multiple gestations, for resuscitation, in heart disease, 431 —432 930-931 Body composition, maternal, in multiple Bichloroacetic acid, for human papillomavirus pregnancies, 414—415 infections, 641 Bonding, maternal-infant, in heart disease, Bicornuate uterus, multiple gestations and, 351 940-94] Bilirubinemia, kernicterus in. See Kernicterus. Borreliosis, stillbirth in, 530 Bioterrorism, 770—773 Botulism, 772 Bipolar diathermy, for selective termination, in Brachial plexus injuries, 39-59 twin—twin transfusion, 485—486 case history of, 49 Birth defects. See Congenital anomalies. diagnosis of, 25—26 epidemiology of, 25, 39-40 Birth injuries, 19-38 evaluation of, 49—53 administration compensation model for, lesions associated with, 25 218-221 mechanisms of, 40-42 avoidable, list of, 221—225 natural history of, 42—43 brachial plexus. See Brachial outcomes of, methodologic issues in, plexus injuries. 43—46 caput succedaneum, 20 pathogenesis of, 25 cephalhematoma, 20 prognosis for, methodologic issues in, cranial, 21—22 43-46 disclosure of, 217—218 treatment of, 26, 46—50, 53-55 epidural hemorrhage, 22-23 types of, 25 CUMULATIVE INDEX Brachiocephalic vessels, development of, Carbon dioxide 838-839 elevated, after resuscitation, 88 —89 monitoring of, in neonatal Bradycardia in complete heart block, 938—939 resuscitation, 83 in resuscitation, 928 —929 Cardiac cachexia, 1017-1018 Brain Cardiac catheterization, in heart disease. abscess of, radiography in, 793 949 —950. 1006— 1007 immaturity of, heart disease and, 1004— 1005 Cardiac cushions, in heart development, 835 injury of cerebral palsy in. See Cerebral palsy Cardiac outflow, defects of, genetic factors in in kernicterus, 126 S48 — 849 timing of, in asphyxia, 69 Cardiac output, maintenance of, before heart malformations of, in heart disease, surgery, 952 1046— 1047 Cardiac tamponade Breastfeeding, of infants with heart from central venous catheter disease, 1026 misplacement, 148~— 149 Breech presentation, of first twin, 468—469 from umbilical venous catheter misplacement, 147 British Research Council, M-scale for muscle testing, 44 Cardiogenesis, 828— 840 Bronchial tree, development of, pulmonary Cardiomyocytes, embrvology of. 828. 830—83 circulation development linked to, Cardiomyopathy S60— 861 asphyxial, hypotension in, 89-90 Burden of proof, in trial, 181 in twin twin transfusion syndrome, 871 iopulmonary bypass in low birth weight infants 1004 LOOS ( neurologic effects of, 104 1048 Cachexia, cardiac, 1017-1018 iovascular system, in multiple gestations, 431 23 9 affeine, for congenital heart disease, 942 1oversion, for supraventriculal alcineurin, in atriov entricular valve tachycardia, 939-940, 982 ~ development, 835 CATCH 22 syndrome, embryology alcium chloride, for arrhythmias, 98] 836 RIN ‘alcium gluconate, for arrhythmias, 981 Catheter(s), intravascular complications of, 141-156 alcium supplementation, in multiple before heart surgery, 953 954 gestations, 408 infections, 144— 145 aloric intake, in heart disease malposition, 146 goals of 1026 peripheral, 148 150 inadequate 1021 1022 thromboembolic events, 142-143 umbilical artery, 145-146 andidate genes, for congenital heart umbilical venous, 146-148 disease, 848 vasospasm, 143 144 andidiasis, 528, 645—647 Catheterization, cardiac, in heart disease, apnography, in neonatal resuscitation, 83 949 —950. 1006— 1007 aptopril, for hypertension, 985—986 Causation proximate, in trial, 182— 183 ‘aput succedaneum, 20 versus standard of care, 2 63-264 ar seat evaluation, in discharge Cefazolin planning, 1035 tor group B streptococcal infections, 583. 611 arbohydrate metabolism, in multiple for neonatal sepsis prevention, 607 gestations, 407 for pyelonephritis, 756 1064 CUMULATIVI INDEX Cefixime, for gonorrhea, 637 vaginal birth after, 469-470 vertex-nonvertex, 461 —463 Cefotaxime, for catheter-induced vertex-vertex, 459-461 infections, 145 resuscitation in, 78—79 eftriaxone Chagas disease, stillbirth in, 530 for chancroid, 636 for gonorrhea, 637-638 Chain of command, failure to initiate, as for pyelonephritis, 756, 758 negligence, 283 for syphilis, 630 Chancroid, 636 ell adhesion molecules, in atrioventricular Char syndrome, aortic arch anomalies in, 8 valve development, 835 CHARGE syndrome, tetralogy of Fallot ell culture, in herpes simplex virus in, 956 infections, 659 Chart review method, for error reporting, 99 entral nervous system. See also Brain. Chest compression, in resuscitation, 928—929 disorders of, in heart disease, 952 infections of, radiography in, 792 Chest infections, radiography in, 793-794 ephalexin, for asymptomatic Chest radiography, in heart disease, 950 bacteriuria, 753 Chickenpox. See Varicella-zoster virus infections. ephalhematoma, 20 Childbirth Injury Prevention Foundation, ephalosporins, for asymptomatic bacteriuria, asphyxia timing method of, 69—70 751. 753 Chlamydia trachomatis infectious erebral palsy maternal, 638—640 asphyxia markers in preterm birth in, 542 brain injury timing and, 69 treatment of, 581 kidney dysfunction, 68—69 neonatal, 543, 549, 638—640 liver dysfunction, 68 nucleated red blood cells, 64—67 Chlorhexidine, for neonatal sepsis organ dysfunction, 67—68 prevention, 610 platelet count, 67 Cholecystitis, radiography in, 7 umbilical artery pH, 63-64 epidemiology of, 61 Chorioamnionitis, 525—526 in infections, 532 cerebral palsy in, 53 pathophysiology of, 62 complications of, 59Q D definition of, 584, 59] Cerebral palsy in multiple gestations, 404, diagnosis of, 524-525, 59] 496-501. 505—506 fever in, 782—77883 in multiple gestations, 436 Cervix cerclage of, in multiple gestations, 393, preterm birth in, 538 risk factors for, 591 446-447 length of stillbirth in, 527—529 in high-order multiple treatment of, 593 —596 gestations, 393 Chorioangiopagus, laser photocoagulation of, in preterm labor prediction, 3 in twin—twin transfusion, 450, 483—485 435, 446 Chorionic villus sampling, in multiple Cesarean section gestations, 358-361] failure to begin in timely manner, as negligence, 284—285 Chorionicity, determination of, 361, 444, for fetal arrhythmias, 902 477-478 for herpes simplex virus infections, Chorioretinitis, toxoplasmic, 710, 720-72 635-636. 662-663 for high-order multiple gestations, Chromosome 22, microdeletion on, in DiGeorge syndrome, 847-849, 950, 397—398 963 —964, 970—972, 975 for twins breech, 468 —469 Chronic lung disease, heart disease with, premature, 465—468 1000— 1002 CUMUIL ATIVE INDEX Ciprofloxacin for giving bad news, 160-161 for anthrax, 77 for preventing malpractice suits, for tularemia, 196—197 for safety promotion, 101 Circulation, fetal. See Fetus(es), circulation of. for sharing information, 16] Circulatory arrest, deep hypothermic, for transfer of care, 159 neurologic effects of, 1048 nonverbal, 165 poor comprehension in, 15 Claims, malpractice scripts for, 166— 167 administrative compensation model for, 218-221 Community resources, for cardiac surgical ] advance lists of avoidable events for, patient 1037 91 996 Compensation schedule, for malpractice bad faith, 188—189 claims, 2J4A32 245 compensation schedule for, 243 —245 escalating costs of, 210—211 Competency, failure to possess, as expert screening of, 238 negligence, 283 for neurologic injuries, 219—221 Computed tomography for vaccine injuries, 218—219 in abdominal abscess, 798 frivolous, 238 in appendicitis, 796 injury threshold for, 246 empyema, 794 medical courts for, 243 infections, radiation exposure no-fault system for, 245—24 55 in, 790 notification of, | liver infections, 794 Clavicle, fractures of, 31 n pancreatitis, 796—797 pelvic abscess, 798 Cleft lip and palate, in DiGeorge syndrome, pyelonephritis, 799 966-967 septic thrombophlebitis, 800 Clindamycin Computers, in medication error prevention for bacterial vaginosis, 621 622. 645 for administration, 116— 1] for endometritis, 810, 812 for dispensing, 116 for group B streptococcal infections, for documenting, 117 583, 611 for order entry, 115 for intra-amniotic infections, 593 for prescribing, 114 for neonatal sepsis prevention, 607 Congenital anomalies linical decision support systems, in in infections, 535 medication error prevention, 115 in multiple gestations, 503 linical mandate for kernicterus prevention, assisted reproductive 132-133 and, 3 SO8 detection of 444 446 fostridium hotulinum toxin, 77 monochorionic twins lotrimazole, for candidiasis, 646—647 selective termination ultrasonography in, lue cells, in bacterial vaginosis, 619, 644 343. 345 oarctation, aortic Congenital heart disease. See pregnancy contraindicated in, 914 spec ific diseases surgical management of, 957—958 database for, 826 5 , eld ge occidioidomycosis, 734 35 fetal altered flow theory of, SAU S84 Collateral source rule, 236 aortic stenosis, 863 — 864. 880-88] arrhythmias, 891—912 olon, necrosis of from umbilical venous catheter misplacement, 147 148 circulation patterns in, 860-861 974-926 ‘ommunication, 157 170 current concepts in, 857—875 challenges in, 158 159 developmental concepts in duration of, 158 845-855 empathetic, 163-165 diagnosis of, 877 890, for addressing difficult issues, 165 921-922, 948 1066 CUMULATIVE INDEX echocardiography in. See delivery room resuscitation in, Echocardiography, fetal. 927-931 embryology of, 825-844 diagnosis of, 1006— 1007 etiologies of, 825-844 drugs for, 979-997 genetic factors in, 826-828, ductal closure and, 926—927 845-855, 950-951 evaluation of, 949-95] heart block with, 902—906 hemodynamic impairment in, hypoplastic left heart syndrome, 1020-1021 865—866 immediate physiologic compromise in twin—twin transfusion in, 934—936 syndrome, 868—872 in DiGeorge syndrome. See interventions for, 862—867 DiGeorge syndrome natural history of, 879-884 in low birth weight infants, pulmonic stenosis/pulmonary 999-1015 atresia with intact ventricular in maternal heart disease, 916 septum, 864 in maternal infections, 730 restrictive atrial communication, in Williams syndrome, 1046—1047 865 —867 incidence of, 826, 845, 913, 1020 teratology in, 839-840 laboratory testing in, 950 transposition of great arteries, maternal—infant bonding in, 866—867 940-94] maternal, pregnancy in, 913-919 medical management of, for growth contraindications to, 914 promotion, 1024—1025 counseling in, 915-916 nutrition for, 1017-1030 management of, 916—918 outcomes of, 884-886, normal hemodynamic changes in, 1010—1012 913-914 practical experience with, 941 —942 risk stratification in, 915—916 prostaglandins for, 931 —934, 942, neonatal, 921-946. See also 956-957 specific defects surgical management of complete heart block, 937—939 birth history and, 948 —949 corrected, long-term outcomes of, delayed, 1007-1009 1047-1057 evaluation for, 949-951 cardiopulmonary bypass and, follow-up care in, 1041 1047-1048 for aortic arch anomalies, 957 deep hypothermic circulatory for aortic coarctation, arrest and, 1048 957-958 family impact in, 1052-1053 for hypoplastic left heart Fontan operation, 1050—1051 syndrome, 958 hypoplastic left heart for patent ductus syndrome, 1051 arteriosus, 959 intraoperative factors in, for pulmonary atresia with 1047—1048 intact ventricular late, 1044 septum, 957 neurodevelopmental, single-ventricle 1046-1049 physiology, 958—959 new strategies and, 1049 r tetralogy of Fallot, postoperative factors in, 1048 956-957 preoperative factors in, r total anomalous 1046-1047 pulmonary venous quality of life in, 1052—1053 return, 955-956 single ventricle, 1045 for transposition of great tetralogy of Fallot, arteries, 954—955 1044-1045 for truncus arteriosus, 955 total anomalous pulmonary growth after, 1023-1024 venous return, 1051 in low birth weight infants, transposition of great arteries, 1006— 1010 1045, 1049-1050 nutritional considerations in, current recommendations for, 1023-1024 941 —942 palliative, 1011-1012 CUMULATIVE INDEX 1067 postoperative phase of, 954, Critical conduct intervals, in medical care, 6 —9 1048— 1049 prenatal diagnosis impact on, Cryothera: py, for human papillomavirus 92] —923 infections, 641 prenatal information for, 948 Cryptococcosis, 734 preoperative management for, 951-954 ‘ Culture with respiratory disorders, amniotic fluid, 585, 589 1006-1010 blood surgical treatment of, 947-961 in endometritis, 808 ~ discharge after, 1031-1042 in pyelonephritis, 755 long-term outcomes of in bacterial vaginosis, 619 i 1047-1057 in cytomegalovirus infections, 673 mortality and morbidity in. in herpes simplex virus infections, 659 B84 886 : in varicella, 684 with gastrointestinal disorders, — 1003—1004 in bacteriuria, 750—751 with respiratory distress syndrome, in pyelonephritis, 755 1006— 1010 Curriculum vitae, for negligence litigation, ; ongenital infections. See Infe. ctions, neonatal 177155—-1177¢6 2 < - y 750 onjoined twins, 341, 450, 476, 489 Cystiias, 70, onotruncal anomaly f: ace syndrome, Cy tokines*s,, iInn inifnecfteicotniso,n s, cceerreebbrraall ppaall sy 836-838, 848-849, 963-964, 975 and, 534 onotr' uncus, aortic and pulmonary valve CyJtoOmeRgaGlo virus s innfoeclti ons development from, 836—838 maternsatea l, il 67711 —681 clinical presentation of, 672 ontractions, threshold of, in multiple diagnosis of. 673—6 gestations, 395— 396 epidemiology of, 6 79] latent, 672 ontrast agents, for radiography, 791 F prevention of, ornea, injury of, 30 stillbirth in, transmission of, 675 oronary circulation, evaluation of, in heart 4 treatment of, 679-680 disease, 949-950 virology of, 67 orticosteroids neonatal, 549, 675—679 antenatal for fetal lung maturation, 585 —586 in multiple gestations, 447 D standea ard of care: for, 256—259 Damages fiore sn eonatal _— sepsis spreeven tion, 609 calcu2 latioonf , 186—188 x15 9179 5A Costs, of medication errors, 109 caps on, 215—217, 240—242 schedule of, 238—239 Counseling on congenital heart disease Databases fetal, 886—887 for congenital heart disease, 826 on pregnancy risk, 915—916 for expert testimony. See Expert on high-order (triplets and quadruplets) testimony, evidence-based multipeleer egeost ations, 391 —392 Death. See als' o Mortality ourts, medical, for malpractice claims, 243 fetal in arrhythmias, 907 oxiella burnetii infections, stillbirth in, 530 in human parvovirus B19 oxsackievirus infections, stillbirth in, 530 infections, /01 neonatal rab lice, 648—649 in infections, 529, 531 ‘ranberry juice, for urinary tract infections, in maternal infections, 529, asymptomatic bacteriuria, 752 in sepsis, 603 '-reactive protein, in multiple gestations, 406 Debridement, in endometritis, 809 1068 CUMULATIVE INDEX Decision making, communication for. Disablement, model of, National Center for See Communication. Medical Rehabilitation Research, 46 Deep hypothermic circulatory arrest, Discharge planning, after cardiac surgery, neurologic effects of, 1048 1031-1042 Defensive medicine, for malpractice claim assessment for, 1032-1037 avoidance, 214—216 car seat evaluation in, 1035 community resources readiness in, 1037 Defibrillation, for arrhythmias, 981 evaluation of, 1041 Delegation, of nursing duties, as negligence, family readiness in, 1036-1037 genetic screening in, 1034—1035 285—286 hearing screening in, 1035 Department of Energy— National Institutes of home readiness in, 1037 Health guidelines, on data sharing, con- immunization status in, 1035-1036 genital heart disease applications of, 847 implementation of, 1038— 1041 infant readiness in, 1033-1034 Deposition, from nurses, 279 metabolic screening in, 1034—1035 Depressor anguli oris muscle, congenital multidisciplinary team for, 1032 hypoplasia of, 27 primary care issues in, 1034 Diabetes mellitus, in multiple gestations, Discipline, medical, for physicians causing 397, 439 injury, 225—226 Diaphragm, p.a ralysis of, in phrenic nerve Disclosure, of medical injuries, 217-218 injury, 27—28 Discovery process, in negligence litigation, Diathermy, for selective termination, in 175-179 twin-—twin transfusion, 485—486 Disopyramide, for arrhythmias, 980 Diazoxide, for hypertension, 985 Dispensing drugs, error prevention in, 116 Dichorionic twin pregnancies biology of, 304, 306 Dispositive motions, in negligence litigation, Down syndrome screening in, 381 178-179 ultrasonography in, 444 Diving reflex, for arrhythmias, 982 Differential agglutination test, in toxoplasmosis, 713, 715 Dizygotic twin pregnancies, biology of, 303-312 DiGeorge syndrome, 963—978 behavioral disorders in, 969-970 DNA methyl transferases, defects of, heart clinical characteristics of, 964—970 disease in, 851 congenital heart disease in, 964—965, Dobutamine, for heart disease, 987, 989 971—974 conotruncal anomalies in, 836 Documentation diagnosis of, 970—975 electronic, in medication error facial dysmorphia in, 968 prevention, 117 feeding disorders in, 967 failure to provide, as negligence, genetic factors in, 847—849, 950, 281-282 963-964, 970—972, 975 of resuscitation, 286—28 hypocalcemia in, 966 Dopamine, for heart disease, 987-989, 1003 immunodeficiency in, 965—966, 974 language disabilities in, 967, 974—975 Double ovulation, multiple gestations neurocognitive disorders in, 969-970 from, 311 otorhinolaryngologic problems in, 968 Down syndrome palate anomalies in, 966-967, 974-975 atrioventricular valve malformation psychiatric disorders in, 969-970 in, 835 speech disabilities in, 967, 974—975 brain disorders in, 1046 Digoxin congenital heart disease in, 950 for arrhythmias prevalence of, 373 fetal, 893, 900 screening for neonatal, 980, 983 in high-order multiple for heart disease, 990—991 gestations, 383